Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | ECE1 | P42892 | 1/20 | 0.53 |
| ▸ | MME | P08473 | 3/20 | 0.52 |
| ▸ | ACE | P12821 | 2/20 | 0.52 |
| ▸ | CPA1 | P15085 | 1/20 | 0.52 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.52 |
| ▸ | TERT | O14746 | 1/20 | 0.42 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | GABRP | O00591 | 2/20 | 0.39 |
| ▸ | GABRD | O14764 | 2/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.39 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL851239 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL1329382 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL26160440 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| Oxalic Acid SCHEMBL23880753 | 0.96 | ALDH1A1 (0.57) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| Benzene SCHEMBL28127008 | 0.96 | ALDH1A1 (0.57) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL23880754 | 0.94 | ALDH1A1 (0.55) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL9067705 | 0.92 | ALDH1A1 (0.53) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL3268775 | 0.92 | ALDH1A1 (0.53) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL30415495 | 0.92 | ALDH1A1 (0.53) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL2476602 | 0.92 | ALDH1A1 (0.53) | ALDH1A1LMNAMAPTPTGS2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1010 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695413-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | Ohio State Innovation Foundation (US) | 2026-02-18 | — | — | EP | claimed |
| US-20250353797-A1 | ENDOPHYTES, ASSOCIATED COMPOSITIONS, AND METHODS OF USE | INDIGO AG INC (US) | 2025-11-20 | — | — | US | claimed |
| WO-2024235128-A9 | ANTIBODY-DRUG CONJUGATE AND PREPARATION METHOD AND USE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2025-06-19 | — | — | WO | claimed |
| US-20250187998-A1 | IDENTIFICATION OF SOIL BACTERIA-ENRICHING AGENTS AND METHODS OF USE THEREOF | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2025-06-12 | — | — | US | claimed |
| US-12297294-B2 | Cortistatin analogues for the treatment of inflammatory and/or immune diseases | BCN PEPTIDES, S.A. (ES) | 2025-05-13 | — | — | US | claimed |
| US-20250123275-A1 | PEPTIDE MODULATORS OF THE INTERACTION BETWEEN HUMAN C-PEPTIDE AND HUMAN ELASTIN RECEPTOR FOR THERAPEUTIC USE | BIOTEMPT BV (NL) | 2025-04-17 | — | — | US | claimed |
| CN-119732395-A | Fresh-keeping antibacterial material based on food freshness indication and application thereof | 浙江科技大学 | 2025-04-01 | — | — | CN | claimed |
| WO-2025064641-A1 | SYNTHETIC COMPOUNDS COMPRISING DIHYDROISOQUINOLINONE MONOMERS | SRI INTERNATIONAL (US) | 2025-03-27 | — | — | WO | claimed |
| WO-2025031383-A1 | BIFUNCTIONAL LINKER COMPOUND, ANTIBODY DRUG CONJUGATE, PREPARATION METHOD FOR ANTIBODY DRUG CONJUGATE, AND USE OF ANTIBODY DRUG CONJUGATE | 杭州爱科瑞思生物医药有限公司 | 2025-02-13 | — | — | WO | claimed |
| CN-119224161-A | Method for detecting various dipeptides in rumen fluid of ruminant | 中国科学院亚热带农业生态研究所 | 2024-12-31 | — | — | CN | claimed |
| EP-0800385-B1 | ORAL SUSTAINED-RELEASE PREPARATION | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2000-12-20 | — | — | EP | claimed |
| US-6113941-A | POLYMER WITH IMIDAZOLE, BENZIMIDAZOLE, TRIAZOLE AND ALANYL GLYCINE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2000-09-05 | — | — | US | claimed |
| EP-0800385-A1 | ORAL SUSTAINED-RELEASE PREPARATION | Takeda Chemical Industries, Ltd. (JP) | 1997-10-15 | — | — | EP | claimed |
| CN-1145365-A | Camptothecin derivatives | TANABE SEIYAKU CO (JP) | 1997-03-19 | — | — | CN | claimed |
| EP-0506628-B1 | Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances | SIGMA TAU IND FARMACEUTI (IT) | 1996-09-18 | — | — | EP | claimed |
| WO-1996010397-A1 | ORAL SUSTAINED-RELEASE PREPARATION | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-04-11 | — | — | WO | claimed |
| EP-0506628-A2 | Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1992-09-30 | — | — | EP | claimed |
| EP-0493511-A1 | BIOSENSOR AND PROCESS FOR PRODUCING IT | PITTNER, Fritz, Ass.Prof.Doz.Dr. (AT) | 1992-07-08 | — | — | EP | claimed |
| EP-0464009-A2 | Oligopeptide derivatives of ipoxantine endowed with immunomodulating activity and pharmaceutical compositions containing same | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1992-01-02 | — | — | EP | claimed |
| WO-1991006625-A1 | BIOSENSOR AND PROCESS FOR PRODUCING IT | PITTNER FRITZ (AT) | 1991-05-16 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12297294-B2 | Cortistatin analogues for the treatment of inflammatory and/or immune diseases | GHSR, GIPR, GHRHR | ALDH1A1 4757/4885LMNA 4606/4885MAPT 3598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.